112
Participants
Start Date
November 30, 2005
Primary Completion Date
June 21, 2010
Study Completion Date
August 12, 2012
cetuximab
Given IV
carboplatin
Given IV
Lombardi Comprehensive Cancer Center at Georgetown University Medical Center, Washington D.C.
Washington Cancer Institute at Washington Hospital Center, Washington D.C.
Rex Cancer Center at Rex Hospital, Raleigh
Duke Comprehensive Cancer Center, Durham
Lurleen Wallace Comprehensive Cancer at University of Alabama - Birmingham, Birmingham
Mayo Clinic Cancer Center, Rochester
Washington University School of Medicine, St Louis
Baylor University Medical Center - Houston, Houston
UCSF Comprehensive Cancer Center, San Francisco
Indiana University Melvin and Bren Simon Cancer Center, Indianapolis
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore
Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute, Boston
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill
M. D. Anderson Cancer Center at University of Texas, Houston
Collaborators (1)
National Cancer Institute (NCI)
NIH
Bristol-Myers Squibb
INDUSTRY
Avon Foundation
OTHER
National Center for Research Resources (NCRR)
NIH
UNC Lineberger Comprehensive Cancer Center
OTHER